Semprex-D

Semprex-D is a brand name of acrivastine/pseudoephedrine, approved by the FDA in the following formulation(s):

SEMPREX-D (acrivastine; pseudoephedrine hydrochloride - capsule; oral)

• 
  Manufacturer: UCB INC
  
  Approval date: March 25, 1994
  
  Strength(s): 8MG;60MG ^[RLD]

Has a generic version of Semprex-D been approved?

No. There is currently no therapeutically equivalent version of Semprex-D available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Semprex-D. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Semprex-D.

See also...

• Semprex-D Consumer Information (Wolters Kluwer)
• Semprex-D Consumer Information (Cerner Multum)
• Acrivastine/Pseudoephedrine Consumer Information (Wolters Kluwer)
• Acrivastine and pseudoephedrine Consumer Information (Cerner Multum)